Guggenheim analyst Joseph Osha has initiated coverage on Oklo with a Neutral rating. The rating establishes a baseline for the company's stock performance as it navigates the market.

Coverage Details

The initiation marks the first formal rating from Guggenheim for Oklo. Joseph Osha, the analyst covering the stock, assigned the Neutral stance based on the firm's evaluation.

Analyst and Rating

The Neutral rating suggests that the stock is expected to perform in line with the broader market or industry averages over the near term.

Oklo Inc. shares rose 1.64% to $59.36 on Tuesday, bucking a broader market decline, as investors reacted positively to the company's recent progress in securing nuclear fuel supply. The S&P 500 was down 1% during the session. The stock movement follows the signing of a Letter of Intent with Centrus Energy Corp. to secure domestic high-assay low-enriched uranium (HALEU) for Oklo’s planned 1.2 GW clean energy campus in southern Ohio. The agreement anticipates a future definitive contract and could include prepayments from Oklo to support fuel supply for the campus buildout. Centrus will supply enough HALEU to power up to five Aurora powerhouses for multiple years, with deliveries scheduled to begin in 2029. This arrangement is viewed as one of the early large-scale HALEU agreements and aligns with Oklo’s strategy to pair commercial power sales with fuel recycling services.

Strategic Alignment and Deployment

The development aligns Centrus’s enrichment capabilities at its American Centrifuge Plant in Pike County with Oklo’s planned Aurora powerhouse campus. Oklo also entered a Memorandum of Understanding with Kiewit Nuclear Solutions Co. to support engineering, procurement, and construction planning for the initial deployments in southern Ohio. Oklo's Aurora powerhouses are designed to provide reliable clean power under a build-own-operate model, using liquid-metal cooling with low-water requirements.

Technical Analysis and Price Action

Despite the gains, Oklo stock remains in a downtrend, trading 4.4% below its 20-day SMA ($62.06), 9.3% below its 50-day SMA ($65.43), and 30.1% below its 200-day SMA ($84.92). A "death cross" formed in February when the 50-day SMA dropped below the 200-day SMA. The Relative Strength Index (RSI) stands at 47.61, indicating neutral momentum as the market searches for direction. Traders are watching key resistance at $66.00, near the 50-day SMA, and support at $53.50, which sits above the 52-week low of $44.88. The 2029 delivery target for HALEU serves as a concrete timeline anchor for the project's execution.

Project Overview